News
Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?
The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...
Professor of Public Health Grant Scofield joins Emile Donovan to discuss the effectiveness of Wegovy and Ozempic, and whether ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results